Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business

MARLBOROUGH, Mass., Dec. 1, 2020 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB... Devices, Acquisitions Boston Scientific, BTG Specialty Pharmaceuticals, Stark International Lux
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news